Magnetic field desensitizes 5-HT1B receptor in brain: pharmacological and functional studies

It was previously suggested that exposure to magnetic fields (MFs) could generate dysfunction of the CNS. The physiological manifestations described lead us to postulate that these symptoms might be related to a dysfunction of the serotonergic system and particularly of the 5-HT(1B) receptors. Accordingly, MFs could modify the conformation of these receptors altering their functional activities. In rat brain membrane preparations, we showed that the affinity constant of 5-HT for 5-HT(1B) receptors was modified under exposure to MFs since K(d) varied from 4.7+/-0.5 to 12+/-3 nM in control and exposed (2.5 mT) membranes, respectively. This effect was intensity-dependent (the sigmoidal dose-response curve was characterized by an EI(50) of 662+/-69 microT and a maximal increase of 321+/-13% of the control K(d)), reversible, temperature-dependent and specific to the 5-HT(1B) receptors. Similar results have also been obtained with the human 5-HT(1B) receptors. In parallel assays, the functional activity of 5-HT(1B) receptors was investigated. The capacity of a 5-HT(1B) agonist to inhibit the cAMP production was reduced by 37% (53.7+/-3.5% to 33.7+/-4.1%) following exposure to MFs and the cellular activity of the receptors (inhibition of the synaptosomal release of 5-HT) also was markedly reduced (66.5+/-3.2% to 28.5+/-4.2%). These results clearly show that in in vitro assays, MF specifically interacts with 5-HT(1B) receptors, inducing structural changes of the protein that result in a functional desensitization of the receptors. Thus, in vivo, exposure to MFs may lead to physiological changes, particularly in the field of mood disorders where the 5-HT system is strongly involved.

[1]  E. Parker,et al.  Characterization of human 5-HT1 receptors expressed in Sf9 insect cells. , 1994, European journal of pharmacology.

[2]  R. Belmaker,et al.  Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  B Conrad,et al.  Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease. , 1999, Neuroreport.

[4]  R. Belmaker,et al.  Transcranial magnetic stimulation: A potential new frontier in psychiatry , 1995, Biological Psychiatry.

[5]  C. Epstein,et al.  The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[6]  T. Zyss,et al.  The influence of rapid-rate transcranial magnetic stimulation (rTMS) parameters on rTMS effects in Porsolt's forced swimming test. , 1999, The international journal of neuropsychopharmacology.

[7]  B. Jacobs,et al.  An animal behavior model for studying central serotonergic synapses. , 1976, Life sciences.

[8]  C. Nemeroff,et al.  Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.

[9]  R. Sandyk,et al.  The association of diabetes mellitus with dementia in Parkinson's disease. , 1992, The International journal of neuroscience.

[10]  M. Frye,et al.  Beyond Lithium in the Treatment of Bipolar Illness , 1998, Neuropsychopharmacology.

[11]  S H Lisanby,et al.  Transcranial Magnetic Stimulation Applications in Neuropsychiatry , 1999 .

[12]  W. Paulus,et al.  Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats , 1999, Brain Research.

[13]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[14]  R. Post,et al.  Repetitive transcranial magnetic stimulation as a neuropsychiatric tool: present status and future potential. , 1999, The journal of ECT.

[15]  R. Post,et al.  Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[16]  M. Hallett,et al.  Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression , 1996, Neurology.

[17]  R. Sandyk Magnetic fields in the therapy of parkinsonism. , 1992, The International journal of neuroscience.

[18]  Mark Hallett,et al.  Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression , 1995, Neuroreport.

[19]  Grahame-Smith Dg Serotonin in affective disorders. , 1992 .

[20]  J. Hyttel,et al.  Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  M. Moskowitz,et al.  Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis , 1999, Neuropharmacology.

[22]  C M Epstein,et al.  Repetitive transcranial magnetic stimulation activates specific regions in rat brain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. R. Adey,et al.  Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Klein,et al.  Chronic repetitive transcranial magnetic stimulation alters β-adrenergic and 5-HT2 receptor characteristics in rat brain , 1999, Brain Research.

[25]  R. Belmaker,et al.  The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression , 1995, Brain Research.

[26]  C. Cotman,et al.  Synaptic plasma membranes from rat brain synaptosomes: isolation and partial characterization. , 1971, Biochimica et biophysica acta.

[27]  Á. Pascual-Leone,et al.  Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression , 1996, The Lancet.

[28]  T. Kenakin The classification of seven transmembrane receptors in recombinant expression systems. , 1996, Pharmacological reviews.

[29]  J. Bockaert,et al.  5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. , 1988, European journal of pharmacology.

[30]  R. Hen,et al.  5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. , 1997, Molecular pharmacology.

[31]  M Feinsod,et al.  Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. , 1999, Archives of general psychiatry.

[32]  R Kavet,et al.  Depressive symptoms and headaches in relation to proximity of residence to an alternating-current transmission line right-of-way. , 1993, American journal of epidemiology.

[33]  M. Moskowitz,et al.  Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin , 1995, British journal of pharmacology.

[34]  R. Belmaker,et al.  Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia , 1996, Biological Psychiatry.

[35]  L. Siever,et al.  Critical issues in defining the role of serotonin in psychiatric disorders. , 1991, Pharmacological reviews.

[36]  M Feinsod,et al.  Preliminary evidence for a beneficial effect of low‐frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia , 1998, Depression and anxiety.

[37]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[38]  M. Moskowitz,et al.  CP‐93,129, sumatriptan, dihydroergotamine block c‐fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges , 1992, British journal of pharmacology.

[39]  M Hallett,et al.  Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[40]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[41]  M. Repacholi Low-level exposure to radiofrequency electromagnetic fields: health effects and research needs. , 1998, Bioelectromagnetics.

[42]  M. Moskowitz,et al.  Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis. , 1999, European journal of pharmacology.